A trader earned a profit of 1.49 million US dollars within two days by trading Meme Coin
According to Lookonchain monitoring, a trader made a profit of $1.49 million in just 2 days by trading MEMEcoin. The trader traded 7 lots of MEMEcoins on March 16 and March 17, all profitable, earning a total of 8,282.8 SOL ($1.49 million).
Initially, this trader was not good at trading MEMEcoin; out of the first ten coins, six were losses with only a success rate of 40%. This trader is very cautious and would not invest more than 80 SOL in tokens. After two weeks of trading, it seems that the trader has mastered the method and started investing over 500 SOL or even over 1,000 SOL. So far he has traded a total of 35 tokens with profits from twenty-five trades resulting in an overall win rate is about71.43%, with total earnings being around8,582.6 SOL ($1.54 million). A whopping96%5%of these profits came from trades conducted during the last two days.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure
According to media reports citing sources familiar with the matter, SpaceX is preparing to complete a debt issuance totaling $40 billion, with an interest rate significantly higher than previous borrowing costs, reflecting growing investor concerns over financing for artificial intelligence (AI) infrastructure.
Tom Lee: The market is in a sell-off state, and tech stocks have reached support levels
TS Lombard scenario analysis: An AI bubble burst could trigger a 30% plunge in the S&P 500, wiping out 20 trillion dollars in market value—but don't rush to short!
Dario Perkins from TS Lombard predicted in a scenario analysis released on Thursday that if AI capital expenditure collapses, approximately $20 trillions in U.S. stock market value could evaporate, triggering credit losses of $125 billions to $190 billions.
Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline
Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.
Crypto prices
More
